System Accuracy of the Blood Glucose Monitor for Personal Use BG-709b
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Diagnostic Test: blood glucose measurement, blood glucose monitor for personal useDiagnostic Test: blood glucose measurement, laboratory reference device
- Registration Number
- NCT05091736
- Lead Sponsor
- Institut fur Diabetes Karlsburg GmbH
- Brief Summary
This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO 15197
- Detailed Description
This study assesses the system accuracy the blood glucose monitoring systems for personal use BG-709b as outlined in DIN EN ISO 15197:2015.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- Male or female patients with clinical indication for blood glucose testing
- Signed form of consent
- Minimum age of 18 years
- Subjects are legally competent and capable to understand character, meaning and consequences of the study
Exclusion Criteria
- Pregnancy or lactation
- Severe acute disease (at study physician's discretion)
- Acute or chronic diseases with inherent risk of aggravation by the procedure (at study physician's discretion)
- Current constitution that does not allow participating in the study (e.g. hematocrit out of the devices's specifications, medication known to influence blood glucose measurements; Appendix A of ISO 15197)
- Being unable to give informed consent
- Age younger than 18 years
- Legally incompetent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Subject glucometer measurement blood glucose measurement, blood glucose monitor for personal use - Subject glucometer measurement blood glucose measurement, laboratory reference device -
- Primary Outcome Measures
Name Time Method Analysis of system accuracy based on DIN EN ISO 15197 day 1 Assessment of the analytical measurement performance of the blood glucose monitor based on procedures defined in DIN EN ISO 15197
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institut für Diabetes Karlsburg GmbH
🇩🇪Karlsburg, Mecklenburg Vorpommern, Germany